Longitudinal Boundary Sharpness Coefficient Slopes Predict Time to Alzheimer’s Disease Conversion in Mild Cognitive Impairment: A Survival Analysis Using the ADNI Cohort
Ishaan Cherukuri 1 * 1 Independent Researcher, USA Corresponding: [email protected] * Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in the analysis or writing of this report. A complete listing of ADNI investigators can be found at: adni.loni.usc.edu/how_to_apply/ADNI_Acknowledgement_List.pdf · 2026
Read Longitudinal Boundary Sharpness Coefficient Slopes Predict Time to Alzheimer’s Disease Conversion in Mild Cognitive Impairment: A Survival Analysis Using the ADNI Cohort by Ishaan Cherukuri 1 * 1 Independent Researcher, USA Corresponding: [email protected] * Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in the analysis or writing of this report. A complete listing of ADNI investigators can be found at: adni.loni.usc.edu/how_to_apply/ADNI_Acknowledgement_List.pdf (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2603-26007.txt.
Description
Cherukuri predicts which patients with mild cognitive impairment will progress to Alzheimer's disease. His marker is the sharpness of the gray-white matter boundary on MRI scans. What matters is not one scan but how fast that boundary fades each year. He analyzes 1,824 scans from 450 ADNI subjects over about five years. Slope features feed a random survival forest. The test C-index reaches 0.63, far above baseline models at 0.24. MRI is much cheaper than PET imaging, he notes. The marker could aid screening and trial enrollment.
Catalog record
| CREATOR | Ishaan Cherukuri 1 * 1 Independent Researcher, USA Corresponding: [email protected] * Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in the analysis or writing of this report. A complete listing of ADNI investigators can be found at: adni.loni.usc.edu/how_to_apply/ADNI_Acknowledgement_List.pdf |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50001 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2603.26007